The tumor lymphocytic infiltration immune class gene signature and CTNNB1 mutation status in subsets of HCC tumors also warrant examination for predictive value in patients treated with ICIs [102,103,104]. The gene discussed is CTNNB1; the disease is hepatocellular carcinoma.